The Saudi Food and Drug Authority (SFDA) signed on April 12, 2022 a memorandum of cooperation (MoC) with the Saudi Epilepsy Society (SES). The MoC aims to promote and develope the professional, research work of professional specialists and educating the community about epilepsy diseases.

The MOC was signed by His Excellency SFDA’s CEO, Dr. Hisham bin Saad Aljadhey, and SES Chairman Dr. Faisal bin Aboud Al-Otaibi.

The memorandum also aims to exchange data, statistics, advisory services, scientific advice, scientific and practical experiences, in addition to information related to the safety, quality and efficiency of medicines.

The memorandum includes supporting research and studies of common relationships, participating in economic studies of epilepsy drugs, making guidelines in the field of epilepsy for health practitioners, awareness campaigns, external events, exhibitions, conferences, and local and international scientific seminars.